[Quantitative immunohistochemical tenascin test in infiltrative duct breast cancer].
27 cases of infiltrative duct breast carcinoma have been studied immunohistochemically. A significant correlation was found between an increase of structures containing tenascin and an increase of tumor metastatic activity.
Zavalishina
L E
LE
Petrov
A N
AN
Andreeva
Iu Iu
IuIu
D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D009361:Neoplasm Invasiveness; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*; D019063:Tenascin / Q000096:biosynthesis*
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D019063:Tenascin